Communication methods and architecture for heart treatment systems

Patent metadata

Field	Value
Publication number	US-12029535-B2
Application number	US-202117354976-A
Country	US
Kind code	B2
Filing date	Jun 22, 2021
Priority date	Mar 29, 2017
Publication date	Jul 9, 2024
Grant date	Jul 9, 2024

Abstract

The present invention generally relates to heart treatment systems. In some aspects, methods and systems are provided for facilitating communication between implanted devices. For example, an implantable cardiac rhythm management device may be configured to communicate with an implantable blood pump. The implantable cardiac rhythm management device may deliver heart stimulation rate information in addition to information associated with any detected abnormalities in heart function. In response, the pump may be configured to adjust pumping by the pump to better accommodate a patient's particular needs.

First claim

What is claimed is:

1. A method of assisting a heart of a patient, the method comprising:
receiving, with a pump processor of an implantable blood pump coupled with a heart of a patient, an electrical pace signal from an implanted cardiac rhythm management device electrically pacing the heart of the patient, wherein the implanted cardiac rhythm management device communicates with the implantable blood pump through conductive pathways through tissue; and
adjusting a pumping protocol of the implantable blood pump based on the received electrical pace signal via conductive pathways with the pump processor.

2. The method of claim 1 , wherein the implanted cardiac rhythm management device communicates with the implantable blood pump through conductive pathways through tissue by emitting an electrical field conducted through tissue.

3. The method of claim 2 , wherein receiving the electrical pace signal with the pump processor of the implantable blood pump comprises detecting the electrical field conducted through tissue with one or more sensors coupled to the implantable blood pump.

4. The method of claim 1 , further comprising communicating bidirectionally among the implantable blood pump and the implanted cardiac rhythm management device.

5. The method of claim 1 , wherein the implanted cardiac rhythm management device communicates with the implantable blood pump through conductive pathways without any additional power for transmission.

6. The method of claim 1 , wherein the implanted cardiac rhythm management device communicates with the implantable blood pump through conductive pathways without an antenna or telemetry coil.

7. The method of claim 1 , wherein the implantable cardiac rhythm management device encodes sensed patient information, time stamp information, heart rate information, abnormal heart rhythm detection information, or patient position or activity information.

8. The method of claim 1 , wherein the electrical pace signal is received by the pump processor with each heart stimulation pulse delivered to the heart of the patient by the implantable cardiac rhythm management device.

9. The method of claim 1 , further comprising determining with the pump processor of the implantable blood pump, a type of abnormal heart rhythm of the heart of the patient detected by the implantable cardiac rhythm management device.

10. The method of claim 9 , wherein the type of abnormal heart rhythm is determined to be a fibrillation of the heart, the pump processor adjusting the pumping protocol to cease pumping of the implantable blood pump for a predetermined duration of time.

11. A heart treatment system, comprising:
an implantable blood pump configured to couple with a circulatory system of a patient and to pump blood therethrough, the implantable blood pump comprising a pump processor and one or more sensors coupled to the implantable blood pump; and
an implantable cardiac rhythm management device configured to deliver heart stimulation pulses to a heart of the patient, wherein the implantable cardiac rhythm management device is configured to communicate an electrical pace signal to the pump processor of the implantable blood pump through conductive pathways through tissue;
wherein the one or more sensors of the implantable blood pump are configured to receive electric fields emitted by the implanted cardiac rhythm management device and conducted through the tissue; and
wherein the pump processor of the implantable blood pump is configured to adjust a pumping of the implantable blood pump based on the electrical pace signal received from the electric fields emitted by the implanted cardiac rhythm management device.

12. The heart treatment system of claim 11 , wherein the implantable cardiac rhythm management device comprises a leadless pacemaker.

13. The heart treatment system of claim 12 , wherein the leadless pacemaker is configured to communicate with the implantable blood pump through conductive pathways without any additional power for transmission.

14. The heart treatment system of claim 12 , wherein the leadless pacemaker is configured to communicate with the implantable blood pump through conductive pathways without an antenna or telemetry coil.

15. The heart treatment system of claim 11 , wherein the implantable blood pump and the implanted cardiac rhythm management device are configured for bidirectional communication.

16. The heart treatment system of claim 11 , wherein the implantable cardiac rhythm management device is configured to encode sensed patient information, time stamp information, heart rate information, abnormal heart rhythm detection information, or patient position or activity information.

17. The heart treatment system of claim 11 , wherein the electrical pace signal is received by the pump processor with each heart stimulation pulse delivered to the heart of the patient by the implantable cardiac rhythm management device.

18. The heart treatment system of claim 11 , wherein the pump processor of the implantable blood pump is configured to determine a type of abnormal heart rhythm of the heart of the patient detected by the implantable cardiac rhythm management device.

19. The heart treatment system of claim 18 , wherein the type of abnormal heart rhythm is determined to be a fibrillation of the heart and wherein the pump processor is configured to cease the pumping of the implantable blood pump for a predetermined duration of time.

20. The heart treatment system of claim 11 , further comprising one or more activity sensors coupled to the implantable cardiac rhythm management device configured to adjust the electrical pacing signal received by the implantable blood pump.

21. The heart treatment system of claim 20 , wherein the one or more activity sensors comprise an electrical pulse detector or accelerometer.

Assignees

• Tc1 Llc

Inventors

• Harjes Daniel I
• Hansen John Freddy
• Stark Iii Joseph C
• Mauro Ghazal Anvar
• Lee Eric
• Callaway Justin A
• Dur Onur

Classifications

• A61M60/232

  Centrifugal pumps · CPC title

• A61M60/221

  the blood flow through the rotating member having both radial and axial components, e.g. mixed flow pumps · CPC title

• A61M60/178

  drawing blood from a ventricle and returning the blood to the arterial system via a cannula external to the ventricle, e.g. left or right ventricular assist devices · CPC title

• A61M60/569

  synchronous with the native heart beat · CPC title

• A61M60/816

  Sensors arranged on or in the housing, e.g. ultrasonic flow sensors · CPC title